The harmful effect of prolonged high-dose methylprednisolone in acute lung injury

被引:9
|
作者
Teng Da [1 ]
Pang Qing-feng [2 ]
Yan Wen-jin [2 ]
Xin, Wing Zhao [2 ]
Xu Chuan-yi [2 ]
机构
[1] Jiangsu Normal Univ, Sch Chem & Chem Engn, Xuzhou 221116, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Dept Pathophysiol, Xuzhou 221002, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Acute lung injury; Methylprednisolone; High dose; Lipopolysaccharide; Rats; RESPIRATORY-DISTRESS-SYNDROME; CRITICAL-APPRAISAL; SEPTIC SHOCK; CORTICOSTEROIDS; MACROPHAGES; INFLAMMATION; VENTILATION; PHASE; MODEL; ARDS;
D O I
10.1016/j.intimp.2012.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although many literatures have shown that prolonged high-dose administration of corticosteroids is hazardous and not indicated to therapy acute lung injury (ALI), there is little information on the harmful effect of prolonged high-dose corticosteroids in acute lung injury. In this study, we aimed to investigate the effect of prolonged high-dose methylprednisolone (MPL) on ALI and improve knowledge regarding the appropriate use of corticosteroids in ALL The different doses of MPL (3, 30, 180 mg.kg(-1)) were given via tail vein injection 1 h after the first time LPS administration and were daily administrated for 14 days. Lung tissues and lavage samples were isolated for biochemical determinations and histological measurements at 12 h, 7 days and 14 days after LPS administration. Single administration of 180 mg.kg(-1) MPL decreased the lung injury score, wet-to-dry ratio, the total cell numbers and level of procollagen type III in BALF at 12 h after LPS challenge. However, prolonged therapy with 180 mg.kg(-1) MPL for 7 days and 14 days decreased the number of AMs in BALF and increased the above-mentioned indexes. These results suggested that the prolonged high-dose MPL has harmful effects to treat LPS-induced ALI in rats. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [1] HIGH-DOSE METHYLPREDNISOLONE AND CNS INJURY
    BRAUGHLER, JM
    HALL, ED
    JOURNAL OF NEUROSURGERY, 1986, 64 (06) : 985 - 986
  • [2] HIGH-DOSE METHYLPREDNISOLONE AND CNS INJURY - REPLY
    BRACKEN, MB
    COLLINS, WF
    EISENBERG, HM
    FLAMM, ES
    PEROT, PL
    SHEPARD, MJ
    WAGNER, FC
    JOURNAL OF NEUROSURGERY, 1986, 64 (06) : 986 - 986
  • [3] Early complications of high-dose methylprednisolone in acute spinal cord injury patients
    Suberviola, Borja
    Gonzalez-Castro, Alejandro
    Llorca, Javier
    Ortiz-Melon, Fernando
    Minambres, Eduardo
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2008, 39 (07): : 748 - 752
  • [4] Should high-dose methylprednisolone be administered in the treatment of acute spinal cord injury?
    Domino, Karen B.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2008, 20 (02) : 136 - 136
  • [5] Effect of methylprednisolone in acute lung injury
    Kiritoshi, M
    Takeyama, N
    Tanaka, T
    4TH INTERNATIONAL CONGRESS ON THE IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS: MECHANISMS AND THERAPEUTIC APPROACHES, 1996, : 587 - 589
  • [6] High-dose methylprednisolone for acute traumatic spinal cord injury A meta-analysis
    Liu, Zhongyu
    Yang, Yang
    He, Lei
    Pang, Mao
    Luo, Chunxiao
    Liu, Bin
    Rong, Limin
    NEUROLOGY, 2019, 93 (09) : E841 - E850
  • [7] High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients
    T Qian
    X Guo
    A D Levi
    S Vanni
    R T Shebert
    M L Sipski
    Spinal Cord, 2005, 43 : 199 - 203
  • [8] EFFECT OF HIGH-DOSE METHYLPREDNISOLONE ON TOURNIQUET ISCHEMIA
    GOTO, H
    BENSON, KT
    KATAYAMA, H
    TONOOKA, M
    TILZER, LL
    ARAKAWA, K
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1988, 35 (05): : 484 - 488
  • [9] High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients
    Qian, T
    Guo, X
    Levi, AD
    Vanni, S
    Shebert, RT
    Sipski, ML
    SPINAL CORD, 2005, 43 (04) : 199 - 203
  • [10] High-dose methylprednisolone for acute closed spinal cord injury - Only a treatment option
    Hugenholtz, H
    Cass, DE
    Dvorak, MF
    Fewer, DH
    Fox, RJ
    Izukawa, DMS
    Lexchin, J
    Tuli, S
    Bharatwal, N
    Short, C
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2002, 29 (03) : 227 - 235